Hubert Hackl

Has grant

Assistant Professor

Medical University of Innsbruck

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hubert Hackl is an Assistant Professor at the Medical University of Innsbruck, Austria. His research primarily focuses on the intersection of cellular signaling, immunobiochemistry, and oncology, as evidenced by his recent publications on the tumor microenvironment, biomarkers for liver failure, and the effects of shock wave therapy. He also explores novel therapeutic approaches in the context of solid tumors and infectious diseases, utilizing machine learning to elucidate complex cellular interactions.

Recent Grants

Grant: Close

MicroRNAs as predictive biomarker for COVID-19 (Co-PI)

Open Date: 2021-07-01

Close Date: 2022-12-01

Grant: Close

Connection of DNA damage and repair with the immunome in high grade serous ovarian cancer

Open Date: 2020-02-01

Close Date: 2022-01-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (12)

Heidi Fiegl

Medical University of Innsbruck

AUSTRIA

View details

Markus Ganzera

Universitätsassistent / Associate Prof

University of Innsbruck

AUSTRIA

View details

Elizabeth Habermann

Professor of Health Services Research

Mayo Clinic

UNITED STATES

View details

Patrick Starlinger

Medical University of Vienna

AUSTRIA

View details

Leo Pölzl

Medical University of Innsbruck

AUSTRIA

View details

Dirk Meyer

Prof.

University of Innsbruck

AUSTRIA

View details

Kai K. Kummer

Medical University of Innsbruck

AUSTRIA

View details

Stefan Coassin

Assistant Professor

Medical University of Innsbruck

AUSTRIA

View details

Andreas Villunger

Medical University of Innsbruck

AUSTRIA

View details

Alice Assinger

Medical University of Vienna

AUSTRIA

View details

Dietmar Fuchs

Associate Professor

Medical University of Innsbruck

AUSTRIA

View details

Véronique M. Braud

Université Côte d'Azur

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hubert Hackl

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Differentially expressed ncRNAs as key regulators in infection of human bronchial epithelial cells by the SARS-CoV-2 Delta variant

Myrobalan Fruit Extracts Modulate Immunobiochemical Pathways In Vitro

Association of the composition of the bone marrow tumor microenvironment in BCR::ABL1-negative myeloproliferative neoplasms with IFN-γ signaling and driver mutations

Preoperative von Willebrand factor is an independent predictive biomarker for post-hepatectomy liver failure—A multivariable model with APRI+ALBI

Impaired surface receptor expression on immature platelets in bleeding patients with abnormal light transmission aggregometry.

Modulation of cell fate by shock wave therapy in ischaemic heart disease

Surgical and oncologic outcomes for liver resections of cystic neuroendocrine tumor liver metastasis

Machine learning to dissect perturbations in complex cellular systems

Modeling omics dose-response at the pathway level with DoseRider

Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment.

Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of Calcification.

Transcriptomic landscapes of effective and failed liver regeneration in humans

An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer.

Hepatocellular carcinoma as predominant cancer subgroup accounting for sex differences in post-hepatectomy liver failure, morbidity and mortality

MIO: microRNA target analysis system for immuno-oncology.

Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications

CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors.

The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents

Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype.

Collaborators (12)

Heidi Fiegl

Markus Ganzera

Elizabeth Habermann

Patrick Starlinger

Leo Pölzl

Dirk Meyer

Kai K. Kummer

Stefan Coassin

Andreas Villunger

Alice Assinger

Dietmar Fuchs

Véronique M. Braud

Make your next move.